Chloroquine-resistant Plasmodium vivax in Papua New Guinea.

Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother (2004) 4.54

History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40

Artemisinin combination therapy for vivax malaria. Lancet Infect Dis (2010) 3.08

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis (2008) 3.01

Current status of malaria and potential for control. Clin Microbiol Rev (2001) 1.92

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother (2007) 1.64

Ownership and usage of mosquito nets after four years of large-scale free distribution in Papua New Guinea. Malar J (2012) 1.45

Plasmodium vivax polymorphism in a clinical drug trial. Clin Diagn Lab Immunol (2001) 1.37

Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect Immun (1998) 1.16

Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay. Antimicrob Agents Chemother (2007) 1.16

In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China. Am J Trop Med Hyg (2011) 1.03

Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar. Antimicrob Agents Chemother (2014) 1.00

The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol (1994) 0.95

Research challenges and gaps in malaria knowledge in Papua New Guinea. Acta Trop (2011) 0.92

Molecular epidemiology of Plasmodium vivax anti-folate resistance in India. Malar J (2011) 0.91

Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J (2014) 0.91

Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg (2009) 0.90

Resistance of infection by Plasmodium vivax to chloroquine in Bolivia. Malar J (2015) 0.89

Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam. Antimicrob Agents Chemother (2015) 0.82

Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening. Malar J (2011) 0.79

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum. Malar J (2012) 0.77

Implications of Plasmodium vivax Biology for Control, Elimination, and Research. Am J Trop Med Hyg (2016) 0.75

Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnel. Malar J (2015) 0.75

In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia. Antimicrob Agents Chemother (2014) 0.75

Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes. PLoS Negl Trop Dis (2017) 0.75

Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet (1978) 5.58

Mefloquine (WR 142,490) in the treatment of human malaria. Science (1975) 5.20

A quinoline methanol (WR 30090) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.85

Effects of chloroquine, quinine, and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg (1968) 2.49

Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1974) 2.22

A phenanthrene methanol (WR 33063) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.05

Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol (1982) 1.96

Chloroquine resistance of Plasmodium falciparum in Brazil detected by a simple in vitro method. Bull World Health Organ (1971) 1.93

Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am J Trop Med Hyg (1996) 1.84

Immunochromatographic test for malaria diagnosis. Lancet (1996) 1.80

Plasmodium falciparum: isolation and purification of spontaneously released merozoites by nylon membrane sieves. Exp Parasitol (1982) 1.70

Malaria in the Australian Defence Force during and after participation in the International Force in East Timor (INTERFET). Med J Aust (2001) 1.55

Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Bull World Health Organ (1974) 1.45

Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ (1979) 1.43

Determination of the drug sensitivity of Plasmodium falciparum. JAMA (1971) 1.33

Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ (1968) 1.33

Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials. J Med Chem (2001) 1.29

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. Antimicrob Agents Chemother (2005) 1.21

Concentration and separation of erythrocytes infected with Plasmodium falciparum by gradient centrifugation. Bull World Health Organ (1979) 1.17

Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg (1987) 1.13

Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. Int J Parasitol (1995) 1.11

In vitro inhibition of the growth of Plasmodium falciparum by Aotus serum. Bull World Health Organ (1979) 1.09

Evaluation of WR250417 (a proguanil analog) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model. Am J Trop Med Hyg (1994) 1.06

A report of scombroid fish poisoning from skipjack tuna (Kutsuwonus pelamis) at Tabubil, Western Province, Papua New Guinea. P N G Med J (1987) 1.05

Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone. Chemotherapy (1990) 1.01

Host failure in treatment of malaria with sulfalene and pyrimethamine. Ann Intern Med (1975) 1.00

Chloroquine bioassay using malaria microcultures. Am J Trop Med Hyg (1993) 0.99

Quinine disposition during malaria and during induced fever. Clin Pharmacol Ther (1976) 0.99

Asymptomatic malaria. Lancet (1970) 0.98

Gametocytocidal and sporontocidal effects of primaquine upon two strains of Plasmodium falciparum. Mil Med (1969) 0.98

Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry (1994) 0.98

A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea. Am J Trop Med Hyg (1966) 0.96

Marker enzymes of Plasmodium falciparum and human erythrocytes as indicators of parasite purity. J Parasitol (1982) 0.94

Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum. Am J Trop Med Hyg (1971) 0.94

Effects of minocycline against chloroquine-resistant falciparum malaria. Am J Trop Med Hyg (1972) 0.94

WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Am J Trop Med Hyg (1997) 0.94

Erythrocytic glutathione reductase, glucose-6-phosphate dehydrogenase, and 6-phosphogluconic dehydrogenase deficiencies in populations of the United States, South Vietnam, Iran, and Ethiopia. J Lab Clin Med (1973) 0.94

Effects of quinine and of chloroquine in vitro against a strain of chloroquine-resistant Plasmodium falciparum that displays a relative resistance to quinine in vivo. Mil Med (1969) 0.93

The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique. Trans R Soc Trop Med Hyg (1983) 0.93

A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report. Trans R Soc Trop Med Hyg (1990) 0.93

Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man. Br J Clin Pharmacol (1990) 0.93

A method for the determination of amodiaquine. Bull World Health Organ (1974) 0.92

Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma. Acta Trop (2003) 0.92

Falciparum malaria: the urgent need for safe and effective drugs. Annu Rev Med (1983) 0.92

Disposable environmental chamber for assessing the drug susceptibility of malaria parasites. Trop Med Parasitol (1993) 0.91

Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture. Ann Trop Med Parasitol (1997) 0.91

Doxycycline for malaria prophylaxis in Australian soldiers deployed to United Nations missions in Somalia and Cambodia. Mil Med (1995) 0.91

Visual test for erythrocytic glucose-6-phosphate dehydrogenase, 6-phosphogluconic dehydrogenase, and glutathione reductase deficiencies. J Lab Clin Med (1973) 0.90

Chemotherapeutic results in a multi-drug resistant strain of Plasmodium falciparum malaria from Vietnam. Mil Med (1974) 0.89

Risk factors of chloroquine resistance in Plasmodium falciparum malaria. Acta Trop (1996) 0.89

The activity of PS-15 in combination with sulfamethoxazole. Trop Med Parasitol (1994) 0.88

Blastoid transformation of lymphocytes in falciparum malaria. Am J Trop Med Hyg (1971) 0.87

Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases anti-malarial activity. J Parasitol (1994) 0.86

Plasmodium falciparum gametocytes. Electron microscopic observations on material obtained by a new method. Am J Trop Med Hyg (1971) 0.86

Isolation of intracellular parasites (Plasmodium falciparum) from culture using free-flow electrophoresis: separation of the free parasites according to stages. J Parasitol (1982) 0.86

Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine. Eur J Clin Pharmacol (1991) 0.86

Visual in-vitro test for determining the drug sensitivity of Plasmodium falciparum. Lancet (1982) 0.85

The chemoprophylactic use of diformyl diaminodiphenyl sulfone (DFD) in falciparum malaria. Am J Trop Med Hyg (1972) 0.85

dCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess. Ann Trop Med Parasitol (1997) 0.85

Diethylcarbamazine in the control of bancroftian filariasis in the Ok Tedi area of Papua New Guinea: phase 2--annual single-dose treatment. P N G Med J (1994) 0.84

Use of rabbit serum in the cultivation of Plasmodium falciparum. J Parasitol (1980) 0.83

Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. Br J Clin Pharmacol (1994) 0.83

Indirect inhibition by antibiotics of nucleotide and deoxynucleotide biosynthesis in Plasmodium falciparum. Southeast Asian J Trop Med Public Health (1998) 0.83

The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax. Trans R Soc Trop Med Hyg (1995) 0.83

Anti-malarial drug resistance, malnutrition and socio-economic status. Trop Med Int Health (1997) 0.83

Chloroquine bioassay of plasma specimens obtained from soldiers on chloroquine plus doxycycline for malaria prophylaxis. Int J Parasitol (1996) 0.83

The influence of acetylator phenotype on the response to sulfalene in individuals with chloroquine-resistant falciparum malaria. Am J Trop Med Hyg (1978) 0.82

A sensitive bioassay for serum cycloguanil using Plasmodium falciparum in vitro. Int J Parasitol (1988) 0.82

Acetylator phenotype and response of individuals infected with a chloroquine-resistant strain of Plasmodium falciparum to sulfalene and pyrimethamine. Am J Trop Med Hyg (1975) 0.82

Acquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant Plasmodium falciparum. Ann Trop Med Parasitol (1967) 0.81

In vivo-in vitro model to assess chloroquine activity in monkeys. Chemotherapy (1995) 0.81

[Clinical studies on chloroquine-resistant Plasmodium falciparum]. Clin Ter (1968) 0.81

Chlorhexidine as an effective agent against Chlamydia trachomatis in vitro and in vivo. Antimicrob Agents Chemother (1979) 0.81

Pigment in asexual erythrocytic forms of chloroquine-resistant Plasmodium falciparum. Ann Trop Med Parasitol (1967) 0.81

Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man. Chemotherapy (1988) 0.81

Drug potentiation against pre-erythrocytic stages of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1971) 0.80

Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro. Parasitol Res (1997) 0.80

In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand. Antimicrob Agents Chemother (1997) 0.80

Effects of diaphenylsulphone (dapsone) against Plasmodium vivax of South West Pacific origin. Trans R Soc Trop Med Hyg (1968) 0.80

Organochlorine insecticide residues in human breast milk: a survey of lactating mothers from a remote area in Papua New Guinea. Bull Environ Contam Toxicol (1993) 0.80

Resistance of Plasmodium falciparum to chemotherapy with 4-aminoquinolines in the Ok Tedi area of Papua New Guinea. P N G Med J (1989) 0.79

Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine. Acta Trop (1997) 0.79

Pharmacokinetics of chlorproguanil in man after a single oral dose of Lapudrine. Chemotherapy (1988) 0.79

Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone. Acta Trop (1997) 0.78

Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1. P N G Med J (1990) 0.78

Efficacy of amodiaquine against a chloroquine-resistant strain of Plasmodium vivax. Trans R Soc Trop Med Hyg (1991) 0.78

Tetracycline prophylaxis for malaria. Lancet (1987) 0.78

Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis. Trans R Soc Trop Med Hyg (2006) 0.77

Effectiveness of doxycycline combined with primaquine for malaria prophylaxis. Med J Aust (1995) 0.77

A bioassay for mefloquine. J Parasitol (1992) 0.77

Congenital malaria due to Plasmodium vivax: a case study in Papua New Guinea. P N G Med J (1986) 0.77

Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force. Med Trop (Mars) (2001) 0.76

A new repository antimalarial agent, CI-564, used in a field trial in New Guinea. Trans R Soc Trop Med Hyg (1967) 0.76

New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine. Antimicrob Agents Chemother (1997) 0.76